HIA
VIVO

Harbor Investment Advisory’s Meridian Bioscience Inc VIVO Stock Holding History

Harbor Investment Advisory’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4
Closed – – 1233
2019
Q4 		$0 Buy
+4
New +$38 ﹤0.01% 1016

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harbor Investment Advisory's VIVO Position: Q1 2020 in Review

Harbor Investment Advisory sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 4 shares.

Harbor Investment Advisory first reported a position in VIVO in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • Harbor Investment Advisory reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • Harbor Investment Advisory sold 4 Meridian Bioscience Inc shares in Q1 2020.
  • Harbor Investment Advisory first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 1 quarter.
  • Harbor Investment Advisory's Meridian Bioscience Inc position peaked at $0 in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Harbor Investment Advisory's 13F filing for Q1 2020, filed 11 May 2020.